Inherited basis of visceral, abdominal subcutaneous and gluteofemoral fat depots

Saaket Agrawal, Minxian Wang, Marcus D. R. Klarqvist, Joseph H. Shin, Hesam Dashti, Nathaniel Diamant, Seung Hoan Choi, Sean J. Jurgens, Patrick T. Ellinor, Anthony Philippakis, Kenney Ng, Melina Claussnitzer, Puneet Batra, Amit V. Khera

Abstract

Body Mass Index (BMI) is a standard but limited metric for assessing metabolic health, as it fails to account for the specific distribution of adipose tissue. This study leverages MRI data from nearly 40,000 UK Biobank participants to map the genetic architecture of specific fat depots: visceral (VAT), abdominal subcutaneous (ASAT), and gluteofemoral (GFAT). By identifying 178 unique genetic loci, the research demonstrates that fat distribution is a highly heritable trait, particularly in females, and is regulated by genes active in the adipocytes rather than the central nervous system. These findings provide a genetic basis for "metabolically unhealthy" fat distribution patterns and offer new avenues for predicting cardiometabolic risk through polygenic scoring.

Introduction: Beyond the BMI

In clinical practice, BMI serves as the primary indicator of obesity. However, BMI is a blunt instrument that cannot distinguish between different types of fat storage. It is well-established that increased visceral adipose tissue (VAT)—the fat surrounding internal organs—is strongly associated with insulin resistance and cardiometabolic disease. Conversely, gluteofemoral adipose tissue (GFAT)—fat stored in the hips and thighs—appears to have a protective effect.

The genetic basis for these differences has historically been studied using anthropometric proxies like the waist-to-hip ratio (WHR). While useful, WHR cannot differentiate between an increase in abdominal fat and a decrease in hip fat. This study addresses this gap by using high-resolution MRI imaging to precisely quantify individual fat depots, allowing for a more granular understanding of the inherited factors driving body shape and health.

Methodology and Data

The researchers analyzed data from up to 38,965 participants in the UK Biobank. Using deep learning models, they automated the quantification of VAT, ASAT, and GFAT volumes from abdominal MRI scans. To isolate the genetics of fat distribution from overall body size, the team analyzed "adjusted" phenotypes (e.g., VAT adjusted for BMI) and ratios between depots (e.g., VAT/GFAT).

The study integrated several genomic approaches:

  1. Common Variant Association Studies (CVAS): Conducted across 27 different contexts, including sex-stratified groups.
  2. Rare Variant Analysis: Utilized exome sequencing from 19,255 individuals to identify high-impact mutations, such as those in the PDE3B gene.
  3. Polygenic Scoring (PGS): Developed scores based on over one million variants to identify individuals at the extremes of the fat distribution spectrum.

Key Genetic Insights

CNS vs. Adipocyte Regulation

A pivotal finding of this research is the divergence in biological drivers between global and local adiposity. While BMI is primarily influenced by genes expressed in the Central Nervous System (CNS)—regulating appetite and energy balance—local fat distribution is largely governed by genes active in the adipocytes (fat cells) and peripheral tissues. This suggests that while the brain determines how much fat we have, the fat cells themselves largely determine where it goes.

The Female Genetic Architecture

The study revealed that fat distribution is significantly more heritable in females than in males. For instance, the heritability of GFAT adjusted for BMI was estimated at 0.53 in females, compared to 0.31 for BMI itself. Furthermore, 25 genetic associations were found to be female-specific, particularly those related to gluteofemoral fat storage.

Polygenic Lipodystrophy

Rare genetic disorders like Familial Partial Lipodystrophy (FPLD) cause severe shifts toward visceral fat and metabolic dysfunction. This study suggests that a "polygenic" version of this condition exists in the general population. Individuals with a high genetic predisposition for visceral fat (or a low predisposition for gluteofemoral fat) exhibit metabolic profiles similar to those with mild lipodystrophy, even without rare monogenic mutations.

Results and Clinical Implications

The study identified 178 unique loci associated with adiposity traits, 29 of which were previously unknown. The predictive power of the polygenic scores was substantial: individuals in the top 5% of the PGS for GFATadjBMI were 3.8 times more likely to have extreme gluteofemoral fat volumes.

Crucially, these genetic markers correlate with clinical outcomes. High polygenic scores for "protective" GFAT were associated with a significantly lower risk of Type 2 Diabetes (OR 0.60) and hypertension. In contrast, high scores for VAT predicted an increased risk for these same conditions, independent of the individual's overall BMI.

Limitations and Future Directions

While the study provides a high-resolution map of the genetics of fat distribution, it is limited by the lack of ancestral diversity, as the UK Biobank cohort is 97% white. Future research must validate these findings in more diverse populations. Additionally, while the associations are robust, functional studies (such as CRISPR-based gene editing in cell lines) are required to elucidate the exact molecular mechanisms by which these loci influence fat storage.

Ultimately, these findings move us closer to a model of precision medicine where genetic risk scores for fat distribution could be used alongside BMI to better identify and manage individuals at high risk for cardiometabolic disease.

Summary updated

Abstract

ABSTRACT For any given level of overall adiposity – as commonly quantified by body mass index (BMI) within clinical practice – individuals vary considerably in fat distribution. We and others have noted that increased visceral fat (VAT) is associated with increased cardiometabolic risk, while gluteofemoral fat (GFAT) may be protective. Familial partial lipodystrophy (FPLD) – often caused by rare variants in the LMNA gene – represents an extreme example of this paradigm, leading to a severe shift to visceral fat with subsequent insulin resistance and adverse metabolic profile. By contrast, the inherited basis of body fat distribution in the broader population is not fully understood. Here, we studied up to 38,965 UK Biobank participants with VAT, abdominal subcutaneous (ASAT), and GFAT volumes precisely quantified using abdominal MRI. Because genetic associations with these raw depot volumes were largely driven by variants known to affect BMI, we next studied six phenotypes of local adiposity: VAT adjusted for BMI (VATadjBMI), ASATadjBMI, GFATadjBMI, VAT/ASAT, VAT/GFAT, and ASAT/GFAT. We identify 178 unique loci associated with at least one adiposity trait, including 29 newly-identified loci. Rare variant association studies extend prior evidence of association for PDE3B as an important modulator of fat distribution. Sex-specific analyses of local adiposity traits noted overall higher estimated heritability in females, increased effect sizes for identified loci, and 25 female-specific associations. Individuals in the extreme tails of fat distribution phenotypes were highly enriched for predisposing common variants, as quantified using polygenic scores. Taking GFATadjBMI as an example, individuals with extreme values were 3.8-fold (95%CI 2.8 to 5.2) more likely to have a polygenic score within the top 5% of the distribution. These results – using more precise and BMI-independent measures of local adiposity – confirm fat distribution as a highly heritable trait with important implications for cardiometabolic health outcomes.
BibTeX
@inproceedings{agrawal2022inherited,
  author = {Saaket Agrawal and Minxian Wang and Marcus D. R. Klarqvist and Joseph H. Shin and Hesam Dashti and Nathaniel Diamant and Seung Hoan Choi and Sean J. Jurgens and Patrick T. Ellinor and Anthony Philippakis and Kenney Ng and Melina Claussnitzer and Puneet Batra and Amit V. Khera},
  title = {{Inherited basis of visceral, abdominal subcutaneous and gluteofemoral fat depots}},
  booktitle = {Nature Communications},
  year = {2022},
  doi = {10.1038/s41467-022-30931-2},
}
Figure